# Modulating intracellular calcium dynamics with alkaloids: A novel strategy against oxidative neurodegeneration

**Authors:** Serap NİĞDELİOĞLU DOLANBAY

PMC · DOI: 10.1093/toxres/tfaf100 · 2025-07-27

## TL;DR

This study explores how alkaloids from a methanol extract protect neurons by restoring calcium balance and reducing oxidative stress.

## Contribution

The study introduces a novel strategy using alkaloids to modulate calcium dynamics and combat oxidative neurodegeneration.

## Key findings

- MAE pretreatment significantly reduced H₂O₂-induced intracellular Ca2+ accumulation in fPC12 cells.
- MAE downregulated key calcium channels and regulatory proteins involved in calcium signaling.
- Molecular docking confirmed strong binding of MAE alkaloids to calcium-handling proteins like SERCA and IP3R.

## Abstract

Calcium homeostasis plays a pivotal role in neuronal function, and its dysregulation is closely associated with oxidative stress-induced neurotoxicity. This study investigated the protective effects of a methanol alkaloid extract (MAE), rich in allocryptopine, tetrahydropalmatine, and tetrahydroberberine N-oxide, on H₂O₂-induced calcium dysregulation in fPC12 cells. Flow cytometry analysis revealed that MAE pretreatment significantly attenuated intracellular Ca2+ accumulation caused by oxidative stress. In line with this, MAE markedly downregulated the mRNA and protein expression levels of CACNA1C (Cav1.2 subunit) and CACNA1D (Cav1.3 subunit), two L-type voltage-gated calcium channels responsible for calcium influx. Furthermore, MAE suppressed the expression of key calcium regulatory proteins, including CALM1, CaMK2A, PMCA (ATP2B1), SERCA (ATP2A1), RyR1, and IP3R (ITPR1), as confirmed by ELISA and Western Blot analysis. Protein–protein interaction (PPI) network analysis demonstrated a highly interconnected and functionally enriched network among these targets, indicating coordinated regulation of calcium signaling pathways. Molecular docking studies supported these findings by showing strong binding affinities of MAE’s isoquinoline alkaloids, particularly tetrahydropalmatine, to SERCA (ATP2A1) and IP3R (ITPR1). These interactions suggest a direct modulatory effect on calcium-handling proteins. Overall, this study provides experimental and in silico evidence that MAE exerts multifaceted neuroprotective effects by restoring calcium homeostasis and modulating oxidative stress responses, highlighting its therapeutic potential in calcium-related neurodegenerative conditions.

## Linked entities

- **Genes:** CACNA1C (calcium voltage-gated channel subunit alpha1 C) [NCBI Gene 775], CACNA1D (calcium voltage-gated channel subunit alpha1 D) [NCBI Gene 776], CALM1 (calmodulin 1) [NCBI Gene 801], CAMK2A (calcium/calmodulin dependent protein kinase II alpha) [NCBI Gene 815], ATP2B1 (ATPase plasma membrane Ca2+ transporting 1) [NCBI Gene 490], ATP2A1 (ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1) [NCBI Gene 487], RYR1 (ryanodine receptor 1) [NCBI Gene 6261], ITPR1 (inositol 1,4,5-trisphosphate receptor type 1) [NCBI Gene 3708]
- **Proteins:** CACNA1C (calcium voltage-gated channel subunit alpha1 C), CACNA1D (calcium voltage-gated channel subunit alpha1 D), CALM1 (calmodulin 1), CAMK2A (calcium/calmodulin dependent protein kinase II alpha), PMCA (plasma membrane calcium ATPase), SERCA (Sarco/endoplasmic reticulum Ca(2+)-ATPase), RYR1 (ryanodine receptor 1), ITPR1 (inositol 1,4,5-trisphosphate receptor type 1)
- **Chemicals:** allocryptopine (PubChem CID 98570), tetrahydropalmatine (PubChem CID 5417), tetrahydroberberine N-oxide (PubChem CID 328042)

## Full-text entities

- **Genes:** RYR1 (ryanodine receptor 1) [NCBI Gene 6261] {aka CCO, CMYO1A, CMYO1B, CMYP1A, CMYP1B, KDS}, CALM1 (calmodulin 1) [NCBI Gene 801] {aka CALML2, CAM2, CAM3, CAMB, CAMC, CAMI}, CAMK2A (calcium/calmodulin dependent protein kinase II alpha) [NCBI Gene 815] {aka CAMKA, CaMKIINalpha, CaMKIIalpha, MRD53, MRT63}, ATP2B1 (ATPase plasma membrane Ca2+ transporting 1) [NCBI Gene 490] {aka MRD66, PMCA1, PMCA1kb}, CACNA1C (calcium voltage-gated channel subunit alpha1 C) [NCBI Gene 775] {aka CACH2, CACN2, CACNA1C-IT2, CACNL1A1, CCHL1A1, CaV1.2}, ATP2A1 (ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1) [NCBI Gene 487] {aka ATP2A, SERCA1}, ITPR1 (inositol 1,4,5-trisphosphate receptor type 1) [NCBI Gene 3708] {aka ACV, CLA4, INSP3R1, IP3R, IP3R1, PPP1R94}, CACNA1D (calcium voltage-gated channel subunit alpha1 D) [NCBI Gene 776] {aka CACH3, CACN4, CACNL1A2, CCHL1A2, Cav1.3, PASNA}
- **Diseases:** neurodegeneration (MESH:D019636), neurotoxicity (MESH:D020258)
- **Chemicals:** H2O2 (MESH:D006861), Ca2+ (-), tetrahydropalmatine (MESH:C014215), allocryptopine (MESH:C109505), Calcium (MESH:D002118), alkaloids (MESH:D000470)
- **Cell lines:** fPC12 — Mus musculus (Mouse), Hybridoma (CVCL_J992)

## Figures

23 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12296383/full.md

---
Source: https://tomesphere.com/paper/PMC12296383